Relmada Therapeutics Congress Trades
NASDAQ: RLMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Dec 12, 2022
Relmada Therapeutics Congress trading summary
Members of Congress have disclosed 2 transactions in Relmada Therapeutics (RLMD) stock, reported by 1 politician. No RLMD trades were reported with a transaction date in the past 12 months. The most active trader is Rep. Chris Jacobs (2).
The latest reported trade is a sale by Chris Jacobs dated Dec 12, 2022 and disclosed on Jan 20, 2023. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading RLMD
RLMD trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
 Chris JacobsR-NYHouse | Sell | $1,001 – $15,000 | Dec 12, 2022 | Filing for Chris Jacobs RLMD trade |
| Chris JacobsR-NYHouse | Buy | $1,001 – $15,000 | Nov 8, 2022 | Filing for Chris Jacobs RLMD trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell RLMD. How Congress trading data works